Pharmaceutical selling in India is a coverage business. Revenue follows the quality and consistency of contact with doctors, chemists, stockists and hospital purchasers, spread across territories a head office cannot observe directly. The recurring problem is not motivation; it is that field activity is self-reported, relationships live on personal phones, and institutional business is forecast from one manager's spreadsheet.
The five criteria
One: is field activity verifiable, with location and time on each visit? Two: does the system model doctors, chemists, stockists and hospitals as distinct account types? Three: are tour plans measurable against actual coverage? Four: is there a real pipeline for institutional and tender business? Five: do chemist and stockist conversations belong to the company rather than to the representative?
Three questions to put to every vendor
Compliance: how does the product support your obligations under the Indian pharma marketing code (UCPMP) and your own internal approval rules? Field conditions: how does the app behave in areas with poor mobile coverage, and which languages do your representatives work in? Fit with existing systems: which ERP, distribution and secondary sales tools must keep running alongside it, and how does data move between them? Ask for answers in writing and test them in a pilot with one territory before a full rollout.
How to compare cost
Compare per-user monthly price, but also implementation fees, add-ons for WhatsApp, telephony and field check-in, and the internal admin time needed to configure the system. A low licence price with heavy setup work can cost more than a higher price on a product that is ready to use.